Abacavir Sulfate: CAS Registry Number 188062-50-2

Abacavir sulfate, chemically defined as registration number 188062-50-2, serves as a powerful HIV medication. It inhibits the proliferation of the human immunodeficiency virus (HIV) by interfering with ANTIPYRINE 60-80-0 the viral enzyme reverse transcriptase. This enzyme is crucial in the HIV life cycle, allowing the virus to integrate its genetic

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleoside reverse transcriptase inhibitor utilized in the treatment of human immunodeficiency virus infection. Its therapeutic properties stem from the potent inhibition of reverse transcriptase, an enzyme essential for HIV replication. Abacavir sulfate is a derivative that transits conversion to its active form, carbovir, w

read more

Top-Tier API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for businesses of all sizes. A leading global API manufacturer and supplier offers a comprehensive range of cutting-edge APIs designed to meet the diverse needs of modern applications. With a proven commitment to quality, innovation, and customer s

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleoside reverse transcriptase inhibitor utilized in the therapy of human immunodeficiency virus infection. Its mechanistic properties stem from the potent inhibition of reverse transcriptase, an enzyme vital for HIV replication. Abacavir sulfate is a pro-drug that undergoes transformation to its active form, carbovir, with

read more

A Top Nutraceutical API Producer

India has firmly established itself as a global hub for nutraceutical ingredient production, particularly in the realm of Active Pharmaceutical Ingredients (APIs). Numerous domestic firms specialize in the specialized production of here natural health active ingredients, serving both the domestic market and exporting globally. These businesses boas

read more